Brief: Y-mAbs Announces Clearance Of IND For GD2-SADA

Y-mAbs Therapeutics

12/07/2022 14:40

July 12 (Reuters) - Y-mAbs Therapeutics Inc  YMAB.O :
    * Y-MABS’ ANNOUNCES CLEARANCE OF IND FOR GD2-SADA
    * Y-MABS THERAPEUTICS INC - EXPECTS A TOTAL OF APPROXIMATELY
59
PATIENTS AT 6-10 U.S. SITES TO BE INCLUDED IN TRIAL

Source text for Eikon:  ID:nGNXcdlXld 
Further company coverage:  YMAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))